Publication
MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Journal Paper/Review - Sep 23, 2020
Wirsching Hans-Georg, Tabatabai Ghazaleh, Ochsenbein Adrian, Roth Patrick, Remonda Luca, Conen Katrin, Caparrotti Francesca, von Moos Roger, Hottinger Andreas F, Hundsberger Thomas, Weller Jonathan, Roelcke Ulrich, Weller Michael
Wirsching, Hans-Georg
7
0
Roelcke, Ulrich
10
0
Weller, Jonathan
1
0
Hundsberger, Thomas
chief of serviceNeurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
118
12
Hottinger, Andreas F
8
0
von Moos, Roger
58
1
Caparrotti, Francesca
4
0
Conen, Katrin
2
0
Remonda, Luca
12
0
Roth, Patrick
16
0
Ochsenbein, Adrian
6
1
Tabatabai, Ghazaleh
6
0
Weller, Michael
34
0